A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

December 31, 2007

Conditions
Procedural Sedation
Interventions
DRUG

AQUAVAN® (fospropofol disodium) Injection

Trial Locations (15)

12601

Hudson Valley Urology, PC, Poughkeepsie

20815

Chevy Chase Clinical Research, Chevy Chase

21122

Chesapeake Research Group, LLC, Pasadena

27710

Duke University Medical Center, Durham

29204

Southern Orthopaedic Sports Medicine, Columbia

29572

Carolina Urologic Research, Myrtle Beach

32256

Borland-Groover Clinic, Jacksonville

40202

University of Louisville, Louisville

59802

International Heart Institute of Montana, Missoula

63017

St. Louis Women's Healthcare Group, Chesterfield

70458

Medical Research Institute, Inc., Slidell

Medical Research Institute, Slidell

75216

Dallas VA Medical Center, Dallas

84070

Physicians' Research Options, Sandy City

85032

Precision Trials, Phoenix

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00327392 - A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures. | Biotech Hunter | Biotech Hunter